Category: Analysis

Analysis, BioTech, business, Finance

Markets Watch: Del Frisco’s Restaurant (NASDAQ:DFRG) Hits Record High

Del Frisco’s Restaurant (NASDAQ:DFRG) reached a record high Wednesday after reporting an improved Q4 year-over-year but fell short of analysts’ expectations. The company also provided fiscal 2014 earnings guidance below Street estimates. Shares are up 0.74% at $24.44, reaching an all-time high of $25.64. The company, which owns and operates Del Frisco’s Double Eagle Steak House, Sullivan’s Steakhouse, and Del Frisco’s Grille, reported Q4 adjusted earnings … Continue reading Markets Watch: Del Frisco’s Restaurant (NASDAQ:DFRG) Hits Record High

John Meady
Analysis, BioTech, business, software

Investor’s Alert: Abercrombie & Fitch (NYSE:ANF), HP (NYSE:HP)

Shares in Abercrombie & Fitch (NYSE: ANF) are up almost 8% pre-market after the retailer reported Q4 earnings that topped expectations. The company said adjusted non-GAAP net income was $104.3 million, or $1.34 per diluted share, more than the $1.05 analysts had been expecting, according to Capital IQ. Q4 GAAP net income was $66.1 million, or $0.85 for the thirteen weeks ended February 1, 2014, … Continue reading Investor’s Alert: Abercrombie & Fitch (NYSE:ANF), HP (NYSE:HP)

Jayne Crisman
FB Nasdaq FB Facebook
Analysis, BioTech, business, Earnings

Trader’s Watch List: ExamWorks, JAKKS Pacific, Inc

Shares of ExamWorks (NYSE: EXAM) jumped to a new all-time high Wednesday, after the provider of independent medical examinations late Tuesday reported a narrowed Q4 net loss that was smaller than expected while revenue topped Street estimates and the company forecast Q1 and 2014 revenue above analysts’ expectations. EXAM was up 17% at $35.76 recently, after hitting the fresh record at $36.85. The company posted … Continue reading Trader’s Watch List: ExamWorks, JAKKS Pacific, Inc

Mark Doerr
Analysis, BioTech, business

Trader’s Alert – Dyax Corp, Boeing, Tyco

Dyax Corp (NASDAQ:DYAX) shares rose 8.1% to $10.99, their highest price since mid-2004, after positive Phase 1a study results of DX-2930, a treatment for hereditary angioedema attacks. The first-in-human clinical study of DX-2930 met all objectives of assessing safety, tolerability and pharmacokinetics and showed it well tolerated at all dose levels. Pharmacokinetic results demonstrated that DX-2930 has linear, dose-dependent exposure and a mean elimination half-life … Continue reading Trader’s Alert – Dyax Corp, Boeing, Tyco

Chris Lewis
Analysis, Services Sector

Watchlist Movers: END, DAL, SUNE

Endeavour International Corporation (NYSE:END), an independent oil and gas company, said a valve in the Rochelle field in the U.K. that had been stuck in the “shut” position has now been opened and production is expected to re-start in the next few days. The Rochelle field came on line in October of 2013. Endeavour has a 44% working interest in the field, which is located … Continue reading Watchlist Movers: END, DAL, SUNE

John Meady
FB Nasdaq FB Facebook
Analysis, news, Tech IPO

Panasonic Talks Boost Tesla (NASDAQ:TSLA) Pre-Market

Tesla (NASDAQ:TSLA) is posting gains in early pre-market trade Wednesday, gaining momentum in the wake of reports the company is in talks with Panasonic about investing nearly $1 billion in a battery factory in the U.S. Panasonic said it was considering various options to strengthen its ties with Tesla, according to multiple media reports citing the Japanese newspaper Nikkei. In Other Pre-Market News Offshore drilling … Continue reading Panasonic Talks Boost Tesla (NASDAQ:TSLA) Pre-Market

Mark Doerr